VOYA Investment Management
OMIC

VOYA Investment Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

VOYA Investment Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-698
Closed -$25.3K – 3029
2023
Q1 		$25.3K Hold
698
– – ﹤0.01% 2859
2022
Q4 		$42.1K Hold
698
– – ﹤0.01% 2868
2022
Q3 		$52.3K Hold
698
– – ﹤0.01% 2892
2022
Q2 		$80K Buy
+698
New +$81.9K ﹤0.01% 2675

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VOYA Investment Management's OMIC Position: Q2 2023 in Review

VOYA Investment Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 698 shares — an estimated $25.3K sold.

VOYA Investment Management first reported a position in OMIC in Q2 2022 and held it in 4 quarters. The position peaked at $80K in Q2 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • VOYA Investment Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • VOYA Investment Management sold 698 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $25.3K.
  • VOYA Investment Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • VOYA Investment Management's Singular Genomics Systems, Inc. Common Stock position peaked at $80K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.